TEST:

Prostatype®

The Prostatype® Test System combines gene expression information with currently used clinical parameters (PSA, Gleason Score, and Tumor Stage) and calculates the so called P-score. The test is based on a unique database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. The gene expressions together with other clinical parameters such as PSA, Gleason and Tumor stage are entered into the Classification of Prostatic Malignancy Algorithm (CPMA) software that is linked to a unique patient data base. The software calculates the so called P-score that provides a measure of how aggressive the cancer is, which facilitates the choice of optimal treatment for the patient.